Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Patty Hajdu, Minister of Health have made a very exciting announcement regarding the launch of the Biomanufacturing and Life Sciences Strategy for Canada.
This strategy coupled with the $2.2 billion from Budget 2021 will strengthen the sector, improve economic growth and allow innovators and start-ups to look for drug development, manufacturing and commercialization locally, which will keep innovation and its intellectual property within Canada.
For all of us at API, this means that we can continue to focus on increasing our drug development, training and manufacturing capacity to address the challenges faced by our industry and academic partners, innovators and start-ups.
Quotes from the Government of Canada press release:
“ Keeping Canadians safe and healthy by making sure they have access to life-saving medicines like critical vaccines is vitally important. By launching this strategy today, our government is helping Canadian companies advance made-in-Canada solutions to global challenges. We are strengthening Canada’s talent pipeline and creating good jobs, while supporting the growth of the biomanufacturing and life sciences industry in Canada that will ensure a safe future for all of us.”
– The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry
“The COVID-19 pandemic has shown us just how important it is to build up Canada’s capacity to produce vaccines and therapeutics. This biomanufacturing and life sciences strategy, complemented by Canada’s world-class clinical trial and regulatory system, will not only support the future health and safety of Canadians, but also offer opportunities in health innovation for drugs and medical devices.”
– The Honourable Patty Hajdu, Minister of Health
Read the press release issued by the federal government: The Government of Canada announces biomanufacturing and life sciences strategy
Learn more about the Biomanufacturing and Life Sciences Strategy